ImmunogenX Alternatives & Competitors

12 companies similar to ImmunogenX — Advancing celiac disease management with Latiglutenase therapy, innovative diagn...

Entero Therapeutics (Nasdaq: ENTO)

A biopharma company focused on the development of targeted, non-systemic therapies for gas...

12 Post-IPO Equity

Boca Raton, United States

Biotechnology Health Care +1

ImmusanT

Pioneering advancements for celiac disease through innovative diagnostics and therapeutic...

Venture round $72.78M

Biotechnology Health Care +1

Biodesix, Inc.

Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Aw...

356 Post-IPO Equity $312.49M

Louisville, United States

Biotechnology Health Care

LinXis Biopharmaceuticals

We target the cells that drive fibrosis

Amsterdam, The Netherland...

Biotechnology Health Care +1

Track all ImmunogenX competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Corrixr Therapeutics

Destroying some of the deadliest squamous cell cancers at their source.

7 Seed $6.53M

Newark, United States

Biotechnology Health Care +1

AVROBIO

Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring perso...

16 Acquired $110.00M

Cambridge, United States

Biotechnology Health Care

BreStem Therapeutics, Inc.

BreStem is a clinical stage biotech company working to fight deadly lung diseases through...

Raleigh, United States

Biotechnology Health Care

CAUSEWAY THERAPEUTICS LIMITED

Pioneering the future of musculoskeletal health with innovative microRNA therapies for com...

1 Venture round $9.75M

Biopharma Biotechnology +3

Latigo Biotherapeutics, Inc.

Uniquely poised to disrupt pain therapy.

57 Series B $285.00M

Thousand Oaks, United Sta...

Biotechnology Health Care +2

AGITECH

AGITECH For Integrated Scientific Instruments, SAE.

Egypt

Biotechnology Health Care

Elypta

Advancing cancer detection

32 Grant $107.83M

Solna, Sweden

Biotechnology Health Care

Noveome Biotherapeutics, Inc.

Transforming the way challenging diseases and conditions are treated.

25 Series E $43.30M

Pittsburgh, United States

Biotechnology Health Care +1

About ImmunogenX

ImmunogenX® is a clinical-stage biotherapeutics company established in 2013, dedicated to advancing celiac disease management. Their flagship product, Latiglutenase, shows promise in revolutionizing the treatment of celiac disease. Supported by leading experts in celiac disease research, ImmunogenX is also developing C...

Business keywords

Celiac Disease, Latiglutenase Therapy, Biotherapeutics, Diagnostic Tools, Gluten Detection, ImmunogenX, Clinical-stage, Mass Spectrometry, Food Safety

Frequently Asked Questions

Companies similar to ImmunogenX include Entero Therapeutics (Nasdaq: ENTO), ImmusanT, Biodesix, Inc., LinXis Biopharmaceuticals, Corrixr Therapeutics. They work in Biotechnology and Health Care and share ImmunogenX's focus on biotherapeutics, celiac disease and diagnostic tools.

Bounce Watch lists 12 companies that share ImmunogenX's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches ImmunogenX and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

ImmunogenX Profile Entero Therapeutics (Nasdaq: ENTO) Alternatives ImmusanT Alternatives Biodesix, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at ImmunogenX on 13 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.